Background: Lifestyle interventions can improve mental and physical health in patients with mental illness, but implementing these in clinical practice seems difficult.
Purpose: Investigate barriers and facilitators for mental health professionals (MHPs) in taking lifestyle histories and referring to lifestyle interventions.
Methods: A cross-sectional national online survey among MHPs. All mental health care institutions, hospital psychiatry departments, associations for nurse specialists, and independent working psychiatrists' organizations in the Netherlands were invited to participate. Ordinal regression analyses were performed to study factors associated with barriers.
Results: 1524 MHPs participated. Barriers were time constraints (45.3%), lack of referral possibilities (33.2%), patient disinterest (25.4%) and lack of knowledge about: effect (25.5%), availability of interventions (57.5%), lifestyle (16.9%), and reimbursement (41.5%). Facilitators included more referral possibilities (44.9%), integration of lifestyle into clinical routine (48.3%), a dedicated tool (41.5%), organizational commitment (41.2%) and lifestyle as standard treatment component (40.3%), and more knowledge about: referral possibilities (51.4%), effect (38.1%), and reimbursement (48.1%). Older MHPs, those who consider their own lifestyle important, and those working in organizations where lifestyle interventions are available experienced fewer barriers.
Conclusions: Organizations should prioritize lifestyle psychiatry by educating staff, integration into clinical routine, and increasing the availability and reimbursements of interventions.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11562272 | PMC |
http://dx.doi.org/10.1177/15598276241261670 | DOI Listing |
J Med Internet Res
January 2025
Department of Internal Medicine, Hospital Clinic, Institut d'Investigacio Biomèdica August Pi i Sunyer, Barcelona, Spain.
Background: Enhancing self-management in health care through digital tools is a promising strategy to empower patients with type 2 diabetes (T2D) to improve self-care.
Objective: This study evaluates whether the Greenhabit (mobile health [mHealth]) behavioral treatment enhances T2D outcomes compared with standard care.
Methods: A 12-week, parallel, single-blind randomized controlled trial was conducted with 123 participants (62/123, 50%, female; mean age 58.
JMIR Form Res
January 2025
Institute of Social Medicine, Occupational Health and Public Health, Leipzig University, Leipzig, Germany.
Background: eHealth interventions constitute a promising approach to disease prevention, particularly because of their ability to facilitate lifestyle changes. Although a rather recent development, eHealth interventions might be able to promote brain health and reduce dementia risk in older adults.
Objective: This study aimed to explore the perspective of general practitioners (GPs) on the potentials and barriers of eHealth interventions for brain health.
Scand J Work Environ Health
January 2025
National Institute for Public Health and the Environment, Center for Prevention, Lifestyle and Health, Department Behaviour and Health, Antonie van Leeuwenhoeklaan 9, 3721 MA Bilthoven, The Netherlands.
Objectives: Many employees combine their work with informal care responsibilities for family and friends, potentially impacting their well-being and sustained employability. This study aimed to investigate the effectiveness of a workplace participatory approach (PA) intervention in supporting working caregivers to prevent and solve problems related to balancing work, private life, and informal care tasks.
Methods: We conducted a two-armed randomized controlled trial (ISRCTN15363783) in which working caregivers either received the PA (N=57), under guidance of an occupational professional serving as process facilitator, or usual care (N=59).
PLoS One
January 2025
Department of Endocrinology and Metabolism, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea.
Sodium-glucose co-transporter 2 inhibitors, such as enavogliflozin, offer promising metabolic benefits for patients with type 2 diabetes (T2D), including glycemic control and improved cardiac function. Despite the clinical evidence, real-world evidence is needed to validate their safety and effectiveness. This study aims to evaluate the effects of weight loss and safety of enavogliflozin administration in patients with T2D in a real-world clinical setting over 24 weeks.
View Article and Find Full Text PDFPLoS One
January 2025
Female Brain & Endocrine Health Research (FemBER) Consortium.
Background: Recent studies have demonstrated a greater risk of dementia in female veterans compared to civilians; with the highest prevalence noted for former service women with a diagnosis of psychiatric (trauma, alcoholism, depression), and/or a physical health condition (brain injury, insomnia, diabetes). Such findings highlight the need for increased and early screening of medical and psychiatric conditions, and indeed dementia, in the female veteran population. Further, they call for a better understanding of the underlying biopsychosocial mechanisms that might confer heightened risk for female veterans, to tailor preventative and interventional strategies that support brain health across the lifespan.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!